Expression of heat shock protein 27 and alpha-crystallins in human retinoblastoma after chemoreduction

S Kase1, J G Parikh, N A Rao

  • 1Doheny Eye Institute, 1450 San Pablo Street, DRVC 211, Los Angeles, CA 90033, USA. nrao@usc.edu

Abstract

Insights

Small heat shock proteins (sHSP) like HSP27 and alphaB-crystallin are highly expressed in retinoblastoma cells after chemotherapy. These proteins may protect tumor cells from anticancer drug-induced apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Ophthalmology

Background:

  • Small heat shock proteins (sHSP) are implicated in anticancer drug resistance.
  • HSP27 and alpha-crystallins are key members of the sHSP family.

Purpose of the Study:

  • To investigate the expression of HSP27 and alpha-crystallins in retinoblastoma.
  • To determine the role of these proteins in chemoresistance.

Main Methods:

  • Immunohistochemistry was used to analyze HSP27 and alpha-crystallin expression.
  • Retinoblastoma tissues from patients with and without preoperative chemotherapy were examined.

Main Results:

  • HSP27 and alphaB-crystallin were highly expressed in viable retinoblastoma cells post-chemotherapy.
  • HSP27 expression was significantly higher in chemotherapy-treated cases (p<0.0001).
  • AlphaA-crystallin expression was significantly lower in chemotherapy-treated cases (p<0.01).

Conclusions:

  • HSP27 and alphaB-crystallin are upregulated in retinoblastoma following chemotherapy.
  • These proteins may confer chemoresistance by inhibiting apoptosis in tumor cells.
  • AlphaA-crystallin does not appear to play a significant role in this protective mechanism.